Skip to main content
Hauptrubriken
Zeitschriften Fortbildung Hebammen Bücher Kongresse & Live-Webinare
Social Media - Folgen Sie uns!
Instagram Facebook LinkedIn Instagram Hebammen
Service
Jobbörse Kundenservice Info & Hilfe
Fokus-Themen
Chronisch-entzündliche Darmerkrankung COVID-19-Update Diabetes Hautpflege Klima & Gesundheit Hygiene Intensivpflege Kardiologische Pflege Mobilisation Nachhaltigkeit Nierenerkrankungen Obstipation Onkologische Pflege Palliativpflege Schmerz Sucht in der Pflege Vielfalt, Gleichberechtigung und Inklusion Wundversorgung
Erweiterte Suche
Anmelden
nach oben
Zeitschrift für Gerontologie und Geriatrie
Erschienen in:

01.08.2011 | Case Report

Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis

verfasst von: S. Ebert, K.-P. Schweiger, R. Nau, MD MSc

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

An 85-year-old man with myasthenia gravis was successfully treated with methotrexate (10 mg/week), pyridostigmine and prednisolone (0–30 mg/day) for over 10 years. Then, he developed dysphagia and lost weight. Gastroscopy revealed Candida esophagitis. The patient received nystatin for 2 weeks. Methotrexate was stopped, and immunosuppressive therapy was continued with prednisolone alone. The patient has now remained in good condition for over 1 year. Although dysphagia is a typical symptom of myasthenia gravis, swallowing disturbances should not be attributed hastily to this disease, since they may also be a complication of therapy.
Vorheriger Artikel Development of the Lie-to-Sit-to-Stand-to-Walk Transfer (LSSWT) test for early mobilization in older patients in geriatric rehabilitation
Nächster Artikel Medien
Literatur
1.
Andersen JB, Engeland A, Owe JF, Gilhus NE (2010) Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. Eur J Neurol 17:1445–1450PubMedCrossRef
2.
Aarli JA (2008) Myasthenia gravis in the elderly: is it different? Ann N Y Acad Sci 1132:238–243PubMedCrossRef
3.
McGrogan A, Sneddon S, de Vries CS (2010) The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 34:171–183PubMedCrossRef
4.
Cook RJ, McParland H, Escudier M (2008) An unusual primary presentation of myasthenia gravis. Br J Oral Maxillofac Surg 46:494–496PubMedCrossRef
5.
Willig TN, Paulus J, Lacau Saint Guily J et al (1994) Swallowing problems in neuromuscular disorders. Arch Phys Med Rehabil 75:1175–1181PubMedCrossRef
6.
Frick T, Fryd DS, Goodale RL et al (1988) Incidence and treatment of candida esophagitis in patients undergoing renal transplantation. Data from the Minnesota prospective randomized trial of cyclosporine versus antilymphocyte globulin-azathioprine. Am J Surg 155:311–313PubMedCrossRef
7.
Gupta KL, Ghosh AK, Kochhar R et al (1994) Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols. Am J Gastroenterol 89:1062–1065PubMed
8.
Mackey JR, Desai S, Larratt L et al (1997) Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant 19:939–942PubMedCrossRef
9.
Vazquez JA (2000) Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clin Trials 1:47–59PubMedCrossRef
Metadaten
Titel
Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis
verfasst von
S. Ebert
K.-P. Schweiger
R. Nau, MD MSc
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 4/2011
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-011-0213-2

Weitere Artikel der Ausgabe 4/2011

Pulmonale Erkrankungen im Alter

  • Editorial

Nachruf Prof. Dr. Winfried Saup

  • Nachruf

Medien

  • Medien

Bewährtes entwickeln, Neues integrieren

  • In eigener Sache

Handgrip strength measurement as a predictor for successful dry powder inhaler treatment

  • Original Contribution

Mitteilungen DGGG

  • Mitteilungen der DGGG